patent.fyi
Applications  /  US 2026/0356920
United States Patent Application Publication

US 2026/0356920 A1

Published
Nov 12, 2026
Filed
Aug 9, 2023
Earliest date on the face
Aug 10, 2022
Classification
C07K 16/104
First published here
Nov 20, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Phenylalanine at position 37

What ifWhat if phenylalanine occupied position 37 in the VH framework?
Claim language“a tyrosine at position 37”

The phenylalanine side chain retains an aromatic ring that packs against neighboring nonpolar side chains. The ring lacks a phenolic hydroxyl, so packing at this position relies on nonpolar contacts.

1.1Lysine at position 45

What ifWhat if lysine occupied position 45 on the exposed framework surface?
Claim language“arginine at position 45”

The lysine side chain presents a primary ammonium group to the solvent. This group supplies a positive charge near neutral pH and forms electrostatic contacts with nearby carboxylate groups.

1.2Conserved framework disulfide

What ifWhat if positions 49 and 69 carried alanine and the domain relied on its conserved framework disulfide for covalent stabilization?
Claim language“cysteines at positions 49 and 69”

Cysteines at positions 22 and 92 form an intradomain disulfide during oxidative folding. This bond joins opposing beta sheets of the immunoglobulin fold.

1.3Glutamate at position 5

What ifWhat if glutamate occupied solvent-exposed position 5?
Claim language“a glutamine at position 5”

The glutamate side chain presents a carboxylate to water near neutral pH. The hydrated carboxylate supplies a polar surface at the amino-terminal end of the framework.

1.3Tryptophan at position 102

What ifWhat if tryptophan occupied position 102 and supplied the aromatic contact at the end of the third binding loop?
Claim language“tyrosine at position 102”

The tryptophan indole packs against a nonpolar surface on the target. Its indole nitrogen donates a hydrogen bond to a suitably positioned target carbonyl.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Capture of textile dye from rinse water

A human VH domain with the internal disulfide between residues 49 and 69 binds a selected textile dye. A terminal biotin tag anchors the domain to streptavidin-coated porous beads packed into a flow cartridge. Textile rinse water passes through the cartridge, and an absorbance measurement at the dye’s absorption maximum tracks breakthrough.

Component substitution

Serine pair in the VH framework

Serine replaces cysteine at positions 49 and 69 in a human VH domain that binds a fluorescent dye, removing the added disulfide from those positions. The native framework disulfide and antigen-binding loops remain in place. Size-exclusion chromatography measures the monomer fraction, and a fluorescence polarization titration measures dye binding after the substitutions.

Parameter or scale variation

Dye binding measurements at two volumes

A purified human VH domain and its fluorescent dye target are mixed in 100-microliter wells of a 96-well plate and 20-microliter wells of a 384-well plate. Each format uses 5 nanomolar dye and a 12-point, twofold dilution series of the VH domain starting at 1 micromolar. A plate reader measures fluorescence polarization after a 30-minute incubation at 25 degrees Celsius, and a dye-only control in each format establishes the baseline.

Combination with existing systems

VH detection on a microfluidic chip

A human VH domain that binds fluorescein is immobilized through a terminal biotin tag on a streptavidin-coated sensing region in a microfluidic chip. An adjacent reference channel carries the same surface chemistry with no immobilized VH domain. After sample loading and a buffer rinse, a microscope measures retained fluorescence in both channels and subtracts the reference signal from the sensing signal.

VH affinity column for tagged proteins

A human VH domain that binds a synthetic peptide tag carries a terminal biotin group and attaches to streptavidin-coated agarose in an affinity column. A clarified lysate containing a tagged recombinant reporter protein flows through the column, and a buffer wash removes unbound material. A solution containing free tag peptide displaces the retained protein, and buffer exchange removes the free peptide from the collected fraction.

Automated or data-driven variant

Automated analysis of dye binding curves

A liquid-handling robot dispenses purified VH variants and a fixed concentration of fluorescent dye into microplate wells, with replicate concentration series and dye-only controls. A plate reader records fluorescence polarization and exports the readings together with their well coordinates. Software joins the readings to the plate map, fits a one-site binding model, and reports the fitted dissociation constant and residuals for each variant.

Specific version of a part

Three framework residue substitutions

The VH framework carries tyrosine at position 37, glutamate at position 44, and arginine at position 45. Glutamate and arginine supply opposite side-chain charges on the surface exposed by the absence of a light-chain partner.

Oxidative formation of paired cysteines

The VH domain carries cysteines at positions 49 and 69 alongside the conserved framework cysteines. During oxidative folding, the thiols at positions 49 and 69 form a second intradomain disulfide.

Lysine and proline framework pair

The framework contains lysine at position 83 and proline at position 84. The lysine side chain presents a primary ammonium group to solvent, and the proline ring restricts the backbone angle at position 84.

Direct binding to lysozyme

An isolated VH domain contacts a surface patch on hen egg-white lysozyme through its binding loops. An optical biosensor measures association and dissociation across a dilution series, with an unrelated immobilized protein serving as a specificity control.

Cite aspatent.fyi, US 2026/0356920 A1, claim 1, first published 2026-11-20T08:53:13-05:00, https://patent.fyi/US20260356920/, SHA-256 9a1d242aa47b2b85754988e5f80a8c93ec72c2a6a8165559d83b3401677d83da
First published
Permanent addresshttps://patent.fyi/US20260356920/
Content fingerprint (SHA-256)9a1d242aa47b2b85754988e5f80a8c93ec72c2a6a8165559d83b3401677d83da
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi